Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon

Alcon (SIX/NYSE: ALC), a global eye care provider, and LENSAR, Inc. (NASDAQ: LNSR), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, have announced that the companies have entered into a definitive merger agreement through which Alcon intends to acquire LENSAR. The acquisition includes ALLY Robotic Cataract Laser Treatment System™, LENSAR’s proprietary Streamline® software technology, and LENSAR legacy laser system, building Alcon’s femtosecond laser-assisted cataract surgery (FLACS) offering.

Latham & Watkins LLP represents LENSAR in the transaction with a team led by Orange County partners Michael Treska and Darren Guttenberg, with associates Tiana Baghdikian, Jack Vanderford, Danny Del Giorno, Daniella Moretti, and Joanna Yam. Advice was also provided on tax matters by Los Angeles partner Eric Cho, with associate Ryan Brenner; on benefits and compensation matters by San Diego partner Holly Bauer and counsel Krisa Benskin, with associate Christina Schrantz; on FDA regulatory matters by Washington D.C. partner Elizabeth Richards, with associate Meryl Bartlett; on public company representation/capital markets matters by Orange County/Bay Area partner Shayne Kennedy, Orange County partner Drew Capurro, and New York partner Ellen Smiley, with associate Catriela Cohen; on intellectual property matters by counsel David Kuiper, with associates Nathan Wages and Jesse Kirkland; on litigation matters by San Diego partner Colleen Smith and Orange County partner Kristin Murphy; on antitrust matters by Bay Area partner Joshua Holian and Washington D.C. partner Patrick English, with associate Suhansi Perera; and on data privacy matters by Bay Area partner Heather Deixler, with associate Ryleigh Chen.